During the past decade, University of Pittsburgh conducted 445 clinical trials. In the 10-year time frame, 445 clinical trials started and 220 clinical trials were completed, i.e. on average, 49.4% percent of trials that started reached the finish line to date. In the past 5 years, 211 clinical trials started and 104 clinical trials were completed. i.e. 49.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Pittsburgh" #1 sponsor was "University of Pittsburgh" with 296 trials, followed by "National Cancer Institute (NCI)" with 35 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 33 trials sponsored, "University of Pennsylvania" with 15 trials sponsored and "NSABP Foundation Inc" with 15 trials sponsored. Other sponsors include 565 different institutions and companies that sponsored additional 325 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Pittsburgh" #1 collaborator was "University of Pittsburgh" with 86 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 64 trials as a collaborator, "National Institute on Aging (NIA)" with 51 trials as a collaborator, "National Institutes of Health (NIH)" with 40 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 33 trials as a collaborator. Other collaborators include 1127 different institutions and companies that were collaborators in the rest 433 trials.

According to Clinical.Site data, the most researched conditions in "University of Pittsburgh" are "HIV Infections" (30 trials), "Obesity" (21 trials), "Breast Cancer" (18 trials), "Depression" (17 trials) and "Alzheimer Disease" (13 trials). Many other conditions were trialed in "University of Pittsburgh" in a lesser frequency.

Most popular intervention types in "University of Pittsburgh" are "Drug" (379 trials), "Behavioral" (216 trials), "Other" (161 trials), "Device" (81 trials) and "Procedure" (59 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (100 trials), "placebo" (17 trials), "laboratory biomarker analysis" (15 trials), "pharmacological study" (12 trials) and "Cyclophosphamide" (6 trials). Other intervention names were less common.

The vast majority of trials in "University of Pittsburgh" are 856 trials for "All" genders, 82 trials for "Female" genders and 24 trials for "Male" genders.

Currently, there are 226 active trials in "University of Pittsburgh". 4 are not yet recruiting, 155 are recruiting, 56 are Active, not recruiting, and 11 are Enrolling by invitation. In total, there were 617 completed trials in University of Pittsburgh, 4 suspended trials, and 77 terminated clinical trials to date.

Out of the total trials that were conducted in University of Pittsburgh, 103 "Phase 1" clinical trials were conducted, 212 "Phase 2" clinical trials and 149 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 43 trials, and there were also 310 trials that are defined as “Not Applicable".

University of Pittsburgh has several departments that took part in Clinical trials: "University of Pittsburgh Cancer Institute (UPCI)" - 508 trials, "University of Pittsburgh School of Nursing" - 12 trials, "University of Pittsburgh Department of Dermatology" - 7 trials, "University of Pittsburgh, Alzheimer's Disease Research Center" - 7 trials, "University of Pittsburgh - Department of Neurology" - 6 trials, "University of Pittsburgh - Medicine - Infectious Diseases" - 6 trials, "UPMC Late-Life Depression, Evaluation, Prevention, and Treatment Program" - 5 trials, "Magee Women's Hospital of UPMC - Reproductive Infectious Disease Research" - 5 trials, "University of Pittsburgh Department of Family Medicine" - 4 trials, "The University of Pittsburgh, Department of Psychiatry" - 4 trials, "University of Pittsburgh Medical Center Emergency Department" - 4 trials, "HIV/AIDS Clinical Research Unit / University of Pittsburgh" - 4 trials, "University of Pittsburgh department of medicine division of Pulmonary, Allergy and Critical Care medicine" - 3 trials, "Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders" - 3 trials, "University of Pittsburgh School of Dental Medicine" - 3 trials, "Department of Cardiothoracic Surgery" - 3 trials, "Language Rehab and Cognition Lab, Department of Communication Sciences and Disorders, School of Health and Rehabilitation Sciences, University of Pittsburgh" - 3 trials, "Univ. of Pittsburgh, Dept. of Rheumatology" - 2 trials, "Neuromotor Recovery and Rehabilitation Lab" - 2 trials, "University of Pittsburgh, Department of Urology" - 2 trials, "University of Pittsburgh Cancer Institute; Division of Medical Oncology" - 2 trials